I've Changed My Mind on Palantir Stock. The Great Repricing Makes It a Buy.

Palantir’s U.S. commercial revenue grew 109% in 2025 to $1.5 billion, with Q4 U.S. commercial revenue up 137%, and management is guiding 2026 revenue above $3.1 billion, implying at least 115% growth. The article highlights strong adoption of the AIP boot camp model across non-tech customers including the U.S. Navy, Tampa General Hospital, Freedom Mortgage, and Centrus Energy, underscoring expanding enterprise use cases. Despite a rich valuation of about 45x forward 2026 sales, the piece argues Palantir’s growth and data-control moat are accelerating the business into its multiple.

Analysis

PLTR is shifting from a “proof-of-concept” narrative to a distribution-story narrative: the key edge is not model quality, but a repeatable conversion engine that collapses enterprise buying friction. That matters because enterprise software often rerates only when revenue becomes more linear and less dependent on long, bespoke implementations; if boot camps are turning evaluation into deployment in days, the company is effectively arbitraging procurement inertia. The second-order effect is that competitors with heavier implementation models will look slower and more services-dependent, which should widen the gap in net retention and expansion economics over the next 4-8 quarters.

The bigger hidden winner is not just PLTR, but adjacent infrastructure beneficiaries that get pulled into the same AI modernization wave. LEU gains optionality if regulated industries and defense customers keep prioritizing sovereign, on-prem, or controlled-data deployments; that shifts demand toward domestic nuclear/energy-security narratives that are underappreciated relative to generic AI infrastructure names. SAP is the subtle loser here: if AI agents can compress ERP migration timelines, the value capture may migrate away from incumbent software layers toward orchestration and automation layers, especially in large upgrade cycles where budget owners now benchmark against far shorter payback periods.

The main risk is not near-term demand collapse but valuation fragility if execution slips even slightly. At this scale, a 1-2 quarter deceleration in commercial growth or evidence that boot camps are front-loading demand rather than creating durable expansions would likely compress multiple expectations fast. The market is pricing a long runway of 100%+ commercial growth; once that becomes merely 50-70%, the stock can derate more from sentiment than fundamentals, even if absolute growth remains strong.

Contrarian read: consensus is probably still underestimating how much of PLTR’s moat comes from deployment control and data residency, not model performance. But the bullish case also assumes that fast conversion rates persist as the customer base broadens; that is the right thing to test over the next 6-12 months. If expansion starts skewing toward a narrower set of highly motivated buyers, the business may be better than the skeptics think, but less scalable than the bulls assume.

Key Decisions for Investors

• Long PLTR on pullbacks over the next 1-3 weeks; prefer staged entry rather than chasing strength. Risk/reward is favorable if commercial growth sustains, but size modestly because the stock can gap down hard on any guidance miss.
• Buy PLTR call spreads 3-6 months out to express upside while capping premium risk. This is the cleaner trade if you believe the multiple can stay elevated, but volatility remains the main enemy.
• Relative-value pair: long PLTR / short SAP over 2-4 quarters. The thesis is that AI-driven workflow compression should favor the layer capturing deployment and automation economics over the incumbent upgrade beneficiary.
• Add a small tactical long in LEU as an indirect beneficiary of sovereign/on-prem AI adoption over the next 6-12 months. The trade works best if defense, healthcare, and regulated-industry AI spend keeps migrating toward controlled infrastructure.
• Set a downside trigger on PLTR if growth momentum visibly normalizes for two consecutive quarters; at that point reduce exposure aggressively, because the stock is likely priced for near-flawless execution.